Guardion Health Sciences, Inc. (GHSI)
NASDAQ: GHSI · IEX Real-Time Price · USD
7.91
-0.22 (-2.71%)
At close: Apr 26, 2024, 11:43 AM
7.90
-0.01 (-0.13%)
After-hours: Apr 26, 2024, 4:00 PM EDT

Guardion Health Sciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018201720162015
Cash & Equivalents
6.3615.914.098.5311.130.684.750.060.01
Short-Term Investments
005000000
Cash & Cash Equivalents
6.3615.919.098.5311.130.684.750.060.01
Cash Growth
-60.02%74.99%6.55%-23.34%1529.89%-85.61%7490.69%351.41%-
Receivables
2.271.921.410.010.080.030.0700
Inventory
2.683.120.370.380.310.360.150.040.03
Other Current Assets
0.570.691.20.170.350.040.110.030.02
Total Current Assets
11.8821.6412.079.0911.871.15.080.140.06
Property, Plant & Equipment
0.030.050.140.70.950.270.10.110.17
Goodwill and Intangibles
0011.260.050.052.022.1800
Other Long-Term Assets
0000.010.010.280.010.010.01
Total Long-Term Assets
0.030.0511.390.771.012.582.290.120.18
Total Assets
11.9221.6923.469.8612.883.687.370.260.25
Accounts Payable
0.611.520.240.610.130.410.460.450.56
Current Debt
000.020.160.1500.030.070.25
Other Current Liabilities
0.72.490.90.30.130.080.010.090.14
Total Current Liabilities
1.324.011.161.070.410.50.50.610.96
Long-Term Debt
0000.270.430000.52
Other Long-Term Liabilities
2.454.510000000
Total Long-Term Liabilities
2.454.5100.270.430000.52
Total Liabilities
3.778.521.161.350.840.50.50.611.47
Total Debt
000.030.430.5900.030.070.77
Debt Growth
--85.37%-94.01%-25.85%---57.22%-90.75%-
Retained Earnings
-93.57-93.72-78.8-54.08-45.51-34.63-26.87-20.65-14.11
Shareholders' Equity
8.157.9222.38.5212.033.196.87-0.35-1.23
Net Cash / Debt
6.3615.99.068.110.540.684.72-0.01-0.76
Net Cash / Debt Growth
-60.01%75.45%11.95%-23.20%1444.01%-85.52%---
Net Cash Per Share
5.0014.1919.1328.3986.7110.14101.52-0.24-27.73
Working Capital
10.5717.6310.918.0211.460.614.58-0.47-0.89
Book Value Per Share
6.417.0647.0629.8698.9847.34147.91-9.51-44.93
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).